BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$793M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
228
New
Increased
Reduced
Closed

Top Buys

1
+$72M
2
+$48M
3
+$42.6M
4
ADPT icon
Adaptive Biotechnologies
ADPT
+$39.3M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$39M

Top Sells

1
+$238M
2
+$62.9M
3
+$45.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
5
DVA icon
DaVita
DVA
+$39.6M

Sector Composition

1 Healthcare 96.41%
2 Industrials 0.94%
3 Technology 0.31%
4 Financials 0.04%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
201
$326K ﹤0.01%
2,270
202
$312K ﹤0.01%
900
203
$307K ﹤0.01%
662
204
$304K ﹤0.01%
1,739
205
$303K ﹤0.01%
+1,100
206
$303K ﹤0.01%
1,365
207
$292K ﹤0.01%
2,700
208
$290K ﹤0.01%
3,500
209
$288K ﹤0.01%
4,300
210
$287K ﹤0.01%
3,600
211
$285K ﹤0.01%
1,350
212
$274K ﹤0.01%
2,100
213
$265K ﹤0.01%
170
214
– –
-15,500
215
– –
-24,000
216
– –
-28,900
217
– –
-367,600
218
– –
-2,400
219
– –
-87,631
220
– –
-3,900
221
– –
-34,500
222
– –
-20,300
223
– –
-31,800
224
– –
-8,500
225
– –
-8,000
6 7 8
9
10